Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCNKS.L Regulatory News (CNKS)

  • There is currently no data for CNKS

Board Changes

5 Nov 2018 07:00

RNS Number : 2648G
Cenkos Securities PLC
05 November 2018
 

 

 

 5 November 2018

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

Cenkos Securities plc

("Cenkos" or the "Company")

 

Board Changes

The Board is pleased to announce that, subject to FCA approval, Jim Durkin is to be appointed as an Executive Director and to the position of Chief Executive Officer once regulatory approval has been received. In the interim period Anthony Hotson remains as the Company's Chief Executive Officer.

Jim, a founding shareholder of the Company, was formerly Cenkos' Chief Executive Officer in the period December 2011 to July 2017. Jim resigned as Chief Executive Officer in July 2017. Jim Durkin has over 30 years' experience in the UK securities industry. During his career he has had substantial experience originating and executing corporate finance transactions across a range of industries including insurance, property, financials and utilities.

The Board today also announces that Gerry Aherne, the Chairman of the Company has informed the Board that he will step down and retire from the Company with immediate effect.

The Board would like to thank Gerry for his commitment and contribution to the Company as Chairman over the past six years and wish him well in the future.

The Board will commence the search for a new Chairman. Jeff Hewitt a Non-executive Director has been appointed as the acting Chairman in the interim period.

Jeff Hewitt the acting Chairman commented that:

"We welcome Jim back to the Company and have every confidence in Jim in leading the Company going forward. Jim is well placed to undertake the role having previously been on the Board and has been actively involved in the successful management of the Company."

AIM Rules disclosure under Schedule 2(g) of the AIM Rules

James John Durkin (known as Jim Durkin) holds 4,985,831 ordinary shares of 1p each in the Company representing 9.01% of the issued share capital of the Company.

In addition to his appointment to the Board, James John Durkin, aged 58, holds or has held the following directorships or partnerships in the past five years:

Current directorships:

JDPL Limited

 

Previous directorships:

Cenkos Securities plc

Cenkos Nominee UK Limited resigned

Cenkos Fund Management Limited

JDPL 2 Limited

 

There is no further information that is required to be disclosed with regards to the appointment of Jim Durkin pursuant to Schedule 2 paragraph (g) of the AIM Rules.

 

For further information, please contact: 

 

Cenkos Securities plc

Jeff Hewitt, Acting Non- Executive Chairman

 

Tel: 0207 397 8900

SPARK Advisory Partners Limited

Matt Davis, Nominated Adviser

 

Tel: 0203 368 3552

Whitman Howard Limited

Nick Lovering, Broker

 

Tel: 0207 659 1224

Buchanan Communications

David Rydell, PR Adviser

 

Tel: 0207 466 5066

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOABJBBTMBBMMJP
Date   Source Headline
17th Mar 202210:14 amRNSForm 8.5 (EPT/NON-RI)
16th Mar 20228:48 amRNSForm 8.5 (EPT/NON-RI)
14th Mar 20228:27 amRNSForm 8.5 (EPT/NON-RI)
11th Mar 20228:37 amRNSForm 8.5 (EPT/NON-RI)
11th Mar 20228:33 amRNSForm 8.5 (EPT/NON-RI)
10th Mar 20229:23 amRNSForm 8.5 (EPT/NON-RI)
10th Mar 20229:09 amRNSForm 8.5 (EPT/NON-RI)
8th Mar 20221:29 pmRNSForm 8.5 (EPT/NON-RI)
8th Mar 20221:26 pmRNSForm 8.5 (EPT/NON-RI)
8th Mar 20229:01 amRNSForm 8.5 (EPT/NON-RI)
7th Mar 20229:10 amRNSForm 8.5 (EPT/NON-RI)
4th Mar 20229:32 amRNSForm 8.5 (EPT/NON-RI)
3rd Mar 20228:40 amRNSForm 8.5 (EPT/NON-RI)
2nd Mar 20228:35 amRNSForm 8.5 (EPT/NON-RI)
1st Mar 20229:03 amRNSForm 8.5 (EPT/NON-RI)
28th Feb 20229:07 amRNSForm 8.5 (EPT/NON-RI)
25th Feb 20229:27 amRNSForm 8.5 (EPT/NON-RI)
22nd Feb 20228:42 amRNSForm 8.5 (EPT/NON-RI)
21st Feb 20228:44 amRNSForm 8.5 (EPT/NON-RI)
21st Feb 20228:44 amRNSForm 8.5 (EPT/NON-RI)
17th Feb 20228:30 amRNSForm 8.5 (EPT/NON-RI)
15th Feb 20228:40 amRNSForm 8.5 (EPT/NON-RI)
15th Feb 20228:38 amRNSForm 8.5 (EPT/NON-RI)
14th Feb 20229:16 amRNSForm 8.5 (EPT/NON-RI)
11th Feb 20229:24 amRNSForm 8.5 (EPT/NON-RI)
11th Feb 20229:22 amRNSForm 8.5 (EPT/NON-RI)
31st Jan 20229:01 amRNSForm 8.5 (EPT/NON-RI)
28th Jan 20228:34 amRNSForm 8.5 (EPT/NON-RI)
27th Jan 20228:17 amRNSForm 8.5 (EPT/NON-RI)
25th Jan 20229:00 amRNSForm 8.5 (EPT/NON-RI)
25th Jan 20228:55 amRNSForm 8.5 (EPT/NON-RI)
19th Jan 20228:42 amRNSForm 8.5 (EPT/NON-RI)
18th Jan 202210:36 amRNSForm 8.5 (EPT/NON-RI)
23rd Dec 20213:39 pmRNSRenewal of the EBT Share Purchase Plan
8th Dec 20218:56 amRNSForm 8.5 (EPT/NON-RI)
26th Nov 20218:37 amRNSForm 8.5 (EPT/NON-RI)
25th Nov 20219:00 amRNSForm 8.5 (EPT/NON-RI)
2nd Nov 202110:14 amRNSForm 8.5 (EPT/NON-RI)
1st Nov 20219:05 amRNSForm 8.5 (EPT/NON-RI)
29th Oct 20211:40 pmRNSBlock Listing Interim Review
28th Oct 202110:25 amRNSForm 8.5 (EPT/NON-RI)
27th Oct 20219:22 amRNSForm 8.5 (EPT/NON-RI)
26th Oct 20218:49 amRNSForm 8.5 (EPT/NON-RI)
25th Oct 20218:30 amRNSForm 8.5 (EPT/NON-RI)
21st Oct 20218:46 amRNSForm 8.5 (EPT/NON-RI)
9th Sep 20217:00 amRNSInterim Results
3rd Sep 20218:43 amRNSForm 8.5 (EPT/NON-RI)
2nd Sep 20218:31 amRNSForm 8.5 (EPT/NON-RI)
1st Sep 20218:30 amRNSForm 8.5 (EPT/NON-RI)
31st Aug 20219:56 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.